Results 251 to 260 of about 99,677 (264)

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

Lancet, The, 2013
Cem Gabay, Paul Emery, Rieke E Alten
exaly  

Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial

Lancet, The, 2016
Dinesh Khanna, Christopher P Denton, Jacob M Van Laar   +2 more
exaly  

Tocilizumab

Reactions Weekly, 2019
openaire   +2 more sources

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

Lancet, The, 2008
Josef S Smolen, Andrea Rubbert-Roth, César R Ramos-Remus   +2 more
exaly  

Tocilizumab–Conjugated Polymer Nanoparticles for NIR‐II Photoacoustic‐Imaging‐Guided Therapy of Rheumatoid Arthritis

Advanced Materials, 2020
Ji Qi, Chao Chen, Liang Song
exaly  

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet Respiratory Medicine,the, 2020
Dinesh Khanna, Jonathan Goldin, Masataka Kuwana   +2 more
exaly  

Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial

Lancet, The, 2016
Peter M Villiger, Stefan Kuchen, Lukas Bütikofer   +2 more
exaly  

Effective treatment of severe COVID-19 patients with tocilizumab

Proceedings of the National Academy of Sciences of the United States of America, 2020
Mingfeng Han, Dongsheng Wang, Binqing Fu
exaly  

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial

Lancet, The, 2008
Masaaki Mori, Takako Miyamae, Tadamitsu Kishimoto   +2 more
exaly  

Tocilizumab

Reactions Weekly, 2012
openaire   +2 more sources